Noutsos Tina, Laidman Alexandra Y, Survela Lesley, Arvanitis Dorra, Segalla Renee, Brown Simon G, Isbister Geoffrey K
Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia; Division of Medicine, Royal Darwin Hospital, Darwin, NT, Australia.
Division of Medicine, Royal Darwin Hospital, Darwin, NT, Australia.
Pathology. 2021 Oct;53(6):746-752. doi: 10.1016/j.pathol.2021.01.008. Epub 2021 Apr 15.
Schistocytosis is the morphological hallmark of the microangiopathic haemolytic anaemia of thrombotic microangiopathy (TMA). Consensus guidelines for manual schistocyte quantitation are available, but limited research has evaluated them. The 2012 International Council for Standardization in Haematology (ICSH) recommends a schistocyte quantitation of 1% as a robust cut-off for significance, with the quantitation including helmet, crescent, triangle and keratocyte poikilocytes; and microspherocytes only in the presence of helmets, crescents/triangles, and keratocytes. We aimed to evaluate the relative contribution of these different poikilocytes to schistocyte counting; compare the ICSH method with our proposed method which counts only cells most specific for red cell fragmentation (helmet, crescent and triangular schistocytes); and evaluate inter- and intra-observer agreement. Blood films were sourced from the Australian Snakebite Project, including non-envenomed and envenomed cases, with and without TMA. In blood films across the range of schistocytosis, the predominant poikilocytes present were helmets and crescents. Triangles, keratocytes and microspherocytes were typically only present when ICSH schistocyte count was >1%. With results dichotomised as <1.0% or ≥1.0%, our proposed new method versus the ICSH method showed almost perfect agreement [observed agreement 95%, Cohen's kappa (κ)=0.84, SE 0.04, 95% CI 0.76-0.92, p<0.005]. Inter-observer strength of agreement for our method was moderate (Fleiss' κ for comparisons between three non-unique microscopists κ=0.50, SE 0.05, 95% CI 0.41-0.59, p<0.005). Intra-observer reproducibility assessed in two microscopists ranged from substantial (Cohen's κ=0.71, SE 0.08, 95% CI 0.55-0.86, p<0.005) to borderline almost perfect agreement (Cohen's κ=0.81, SE 0.07, 95% CI 0.68-0.93, p<0.005). Schistocyte quantitation using our new method is simpler than the 2012 ICSH method and had almost perfect agreement. Our finding of moderate inter-observer agreement in quantitating helmet, triangle and crescent schistocytes is applicable to both the ICSH and our newly proposed method. This finding underscores the importance of clinicopathological correlation and repeated examinations in the context of a clinically suspected TMA.
裂红细胞症是血栓性微血管病(TMA)所致微血管病性溶血性贫血的形态学特征。目前已有关于手工定量裂红细胞的共识指南,但对其进行评估的研究有限。2012年国际血液学标准化委员会(ICSH)建议将裂红细胞定量1%作为有意义的可靠临界值,定量时包括盔形、新月形、三角形和棘形异形红细胞;仅在存在盔形、新月形/三角形和棘形红细胞时才计入小球形红细胞。我们旨在评估这些不同异形红细胞对裂红细胞计数的相对贡献;将ICSH方法与我们提出的仅对红细胞碎片最具特异性的细胞(盔形、新月形和三角形裂红细胞)进行计数的方法进行比较;并评估观察者间和观察者内一致性。血涂片来自澳大利亚蛇咬伤项目,包括未中毒和中毒病例,有或无TMA。在裂红细胞症范围内的血涂片中,主要的异形红细胞是盔形和新月形。三角形、棘形红细胞和小球形红细胞通常仅在ICSH裂红细胞计数>1%时出现。将结果分为<1.0%或≥1.0%,我们提出的新方法与ICSH方法显示出几乎完美的一致性[观察到的一致性为95%,科恩kappa系数(κ)=0.84,标准误0.04,95%置信区间0.76 - 0.92,p<0.005]。我们方法的观察者间一致性强度为中等(三位非唯一显微镜检查者之间比较的Fleiss' κ=0.50,标准误0.05,95%置信区间0.41 - 0.59,p<0.005)。在两位显微镜检查者中评估的观察者内重复性范围从高度一致(科恩kappa系数κ=0.71,标准误0.08,95%置信区间0.55 - 0.86,p<0.005)到临界几乎完美一致(科恩kappa系数κ=0.81,标准误0.07,95%置信区间0.68 - 0.93,p<0.005)。使用我们的新方法进行裂红细胞定量比201年ICSH方法更简单,且几乎完美一致。我们在定量盔形、三角形和新月形裂红细胞时观察者间一致性中等的发现适用于ICSH方法和我们新提出的方法。这一发现强调了在临床怀疑TMA的情况下临床病理相关性和重复检查的重要性。